Optimization of a self antigen for presentation of multiple epitopes in cancer immunity Journal Article


Authors: Guevara-PatiƱo, J. A.; Engelhorn, M. E.; Turk, M. J.; Liu, C.; Duan, F.; Rizzuto, G.; Cohen, A. D.; Merghoub, T.; Wolchok, J. D.; Houghton, A. N.
Article Title: Optimization of a self antigen for presentation of multiple epitopes in cancer immunity
Abstract: T cells recognizing self antigens expressed by cancer cells are prevalent in the immune repertoire. However, activation of these autoreactive T cells is limited by weak signals that are incapable of fully priming naive T cells, creating a state of tolerance or ignorance. Even if T cell activation occurs, immunity can be further restricted by a dominant response directed at only a single epitope. Enhanced antigen presentation of multiple epitopes was investigated as a strategy to overcome these barriers. Specific point mutations that create altered peptide ligands were introduced into the gene encoding a nonimmunogenic tissue self antigen expressed by melanoma, tyrosinase-related protein-1 (Tyrp1). Deficient asparagine-linked glycosylation, which was caused by additional mutations, produced altered protein trafficking and fate that increased antigen processing. Immunization of mice with mutated Tyrp1 DNA elicited cross-reactive CD8+ T cell responses against multiple nonmutated epitopes of syngeneic Tyrp1 and against melanoma cells. These multispecific anti-Tyrp1 CD8+ T cell responses led to rejection of poorly immunogenic melanoma and prolonged survival when immunization was started after tumor challenge. These studies demonstrate how rationally designed DNA vaccines directed against self antigens for enhanced antigen processing and presentation reveal novel self epitopes and elicit multispecific T cell responses to nonimmunogenic, nonmutated self antigens, enhancing immunity against cancer self antigens.
Keywords: survival; nonhuman; neoplasms; antigen expression; cd8+ t lymphocyte; cd8-positive t-lymphocytes; t-lymphocytes; mouse; animals; mice; melanoma; models, biological; animal experiment; animal model; drug effect; mutational analysis; mice, inbred c57bl; antigen presentation; dna; immune response; immunogenicity; epitope; glycosylation; autoantigens; tumor immunity; autoimmunity; dna vaccine; point mutation; cross reaction; antigen binding; hla a antigen; tyrosinase related protein 1; oxidoreductases; t lymphocyte activation; asparagine; major histocompatibility antigen class 1; immunization; epitopes
Journal Title: Journal of Clinical Investigation
Volume: 116
Issue: 5
ISSN: 0021-9738
Publisher: American Society for Clinical Investigation  
Date Published: 2006-05-01
Start Page: 1382
End Page: 1390
Language: English
DOI: 10.1172/jci25591
PUBMED: 16614758
PROVIDER: scopus
PMCID: PMC1435720
DOI/URL:
Notes: --- - "Cited By (since 1996): 41" - "Export Date: 4 June 2012" - "CODEN: JCINA" - "Source: Scopus"
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Mary Turk
    10 Turk
  2. Jedd D Wolchok
    905 Wolchok
  3. Taha Merghoub
    364 Merghoub
  4. Adam D Cohen
    44 Cohen
  5. Fei Duan
    6 Duan
  6. Cailian Liu
    60 Liu
  7. Alan N Houghton
    364 Houghton
  8. Gabrielle A Rizzuto
    31 Rizzuto